Finance

Lists
300357:SHE
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
18,87 CN¥
-0,42%
(-0,080) 1D
16 қаз., 15:04:19 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300357...
Open
19,15 CN¥
High
19,56 CN¥
Low
18,69 CN¥
Mkt. cap
9,88 млрд
Avg. vol.
8,68 млн
Volume
5,96 млн
Dividend
1,32%
Quarterly dividend
0,06 CN¥
Ex-dividend date
2026 ж. 09 шіл.
P/E ratio
23,67
52-wk high
35,84 CN¥
52-wk low
18,65 CN¥
EPS
0,80 CN¥
Shares outstanding
523,58 млн
No. of employees
2 мың
Open
19,15 CN¥
High
19,56 CN¥
Low
18,69 CN¥
Mkt. cap
9,88 млрд
Avg. vol.
8,68 млн
Volume
5,96 млн
Dividend
1,32%
Quarterly dividend
0,06 CN¥
Ex-dividend date
2026 ж. 09 шіл.
P/E ratio
23,67
52-wk high
35,84 CN¥
52-wk low
18,65 CN¥
EPS
0,80 CN¥
Shares outstanding
523,58 млн
No. of employees
2 мың
News stories
From web sources and news partners
About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
CEO-
Employees1,81 мың
Founded2002 ж. 19 қыр.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
369,12 млн
209,04 млн
252,84 млн
261,32 млн
Cost of goods sold
15,75 млн
11,11 млн
12,02 млн
12,18 млн
Cost of revenue
15,75 млн
11,11 млн
12,02 млн
12,18 млн
Research and development expenses
26,87 млн
31,40 млн
24,91 млн
22,99 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
134,52 млн
128,79 млн
117,09 млн
118,40 млн
Operating expense
166,35 млн
160,79 млн
143,93 млн
143,60 млн
Total operating expenses
182,11 млн
171,90 млн
155,95 млн
155,79 млн
Operating income
187,02 млн
37,15 млн
96,89 млн
105,54 млн
Other non operating income
160,14 м.
-246,72 м.
-24,48 мың
-175,66 м.
EBT including unusual items
194,75 млн
38,43 млн
131,78 млн
108,66 млн
EBT excluding unusual items
194,31 млн
41,38 млн
131,03 млн
109,00 млн
Income tax expense
29,94 млн
5,57 млн
15,27 млн
16,59 млн
Effective tax rate
15,37%
14,51%
11,59%
15,27%
Other operating expenses
972,53 м.
5,99 млн
-2,31 млн
3,23 млн
Net income
167,86 млн
36,07 млн
119,23 млн
94,22 млн
Net profit margin
45,47%
17,26%
47,16%
36,05%
Earnings per share
-
-
-
-
Interest and investment income
7,32 млн
4,67 млн
34,39 млн
3,81 млн
Interest expense
-190,02 м.
-196,48 м.
-233,08 м.
-172,40 м.
Net interest expenses
7,13 млн
4,48 млн
34,16 млн
3,64 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
197,88 млн
49,60 млн
109,35 млн
119,27 млн
Gain or loss from assets sale
630,07 м.
-630,07 м.
-
-
AI content may include mistakes. Learn more
Google қолданбалары